These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 23991559)

  • 21. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
    Picken MM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amyloidosis following juvenile chronic arthritis in a 3-year-old child].
    Rebaud P; David L; Chatelain P; Colon S; Bouvier R; François R
    Pediatrie; 1985; 40(5):399-402. PubMed ID: 4080507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis.
    Matsuura M; Abe H; Tominaga T; Sakurai A; Murakami T; Kishi S; Bando Y; Minakuchi J; Nagai K; Doi T
    J Med Invest; 2017; 64(3.4):217-221. PubMed ID: 28954985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement.
    Schreml S; Szeimies RM; Vogt T; Landthaler M; Schroeder J; Babilas P
    Eur J Dermatol; 2010; 20(2):152-60. PubMed ID: 20071301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal amyloidosis: current views on pathogenesis and impact on diagnosis.
    Herrera GA; Teng J; Turbat-Herrera EA
    Contrib Nephrol; 2011; 169():232-246. PubMed ID: 21252523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amyloidosis. Also a heart disease].
    García-Pavía P; Tomé-Esteban MT; Rapezzi C
    Rev Esp Cardiol; 2011 Sep; 64(9):797-808. PubMed ID: 21775043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of AL amyloidosis.
    Sezer O; Eucker J; Jakob C; Possinger K
    Clin Nephrol; 2000 Jun; 53(6):417-23. PubMed ID: 10879660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and origin of amyloid in kidney biopsies.
    von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
    Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical outcome of renal amyloidosis.
    Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H
    Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AA amyloidosis: Mount Sinai experience, 1997-2012.
    Bunker D; Gorevic P
    Mt Sinai J Med; 2012; 79(6):749-56. PubMed ID: 23239212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary (AA) amyloidosis in Crohn's disease].
    Bulum T; Prkacin I; Cavrić G; Sobocan N; Skurla B; Duvnjak L; Bulimbasić S
    Acta Med Croatica; 2011; 65(3):271-8. PubMed ID: 22359896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloidosis.
    Pinney JH; Hawkins PN
    Ann Clin Biochem; 2012 May; 49(Pt 3):229-41. PubMed ID: 22402917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid cardiomyopathy.
    Karafiatova L; Pika T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Case of nephrotic syndrome due to AL-type primary amyloidosis associated with renal cell carcinoma].
    Takano M; Suda N; Ichihara A; Konishi K; Sasamura H; Hayashi K; Hashiguchi A; Miyajima A; Murai M; Itoh H
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1014-9. PubMed ID: 18186230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.
    Falk RH; Alexander KM; Liao R; Dorbala S
    J Am Coll Cardiol; 2016 Sep; 68(12):1323-41. PubMed ID: 27634125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival].
    Esteve V; Almirall J; Ponz E; García N; Ribera L; Larrosa M; Andreu X; García M
    Nefrologia; 2006; 26(2):212-7. PubMed ID: 16808259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.